gilteritinib-resistant FLT3 mutants [plasma membrane]

Stable Identifier
R-HSA-9699533
Type
Set [DefinedSet]
Species
Homo sapiens
Compartment
Locations in the PathwayBrowser
Literature References
PubMed ID Title Journal Year
32040554 Gilteritinib is a clinically active FLT3 inhibitor with broad activity against FLT3 kinase domain mutations

Tarver, TC, Hill, JE, Rahmat, L, Perl, AE, Bahceci, E, Mori, K, Smith, CC

Blood Adv 2020
27908881 Preclinical studies of gilteritinib, a next-generation FLT3 inhibitor

Lee, LY, Hernandez, D, Rajkhowa, T, Smith, SC, Raman, JR, Nguyen, B, Small, D, Levis, M

Blood 2017
Participants
Participant Of
Disease
Name Identifier Synonyms
cancer 162 malignant tumor, malignant neoplasm, primary cancer
Cite Us!